These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Diagnostic use of the immunoperoxidase technique for cutaneous plasma cell lesions. Gal R; Kolkov Z; Aronof A; Strauss M; Kessler E Isr J Med Sci; 1985 Aug; 21(8):675-8. PubMed ID: 3899992 [TBL] [Abstract][Full Text] [Related]
27. Multiple myeloma: diagnosis and treatment. Nau KC; Lewis WD Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734 [TBL] [Abstract][Full Text] [Related]
28. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells. Sezer O; Heider U; Zavrski I; Possinger K Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540 [TBL] [Abstract][Full Text] [Related]
29. Plasma cell acid phosphatase and prognosis in multiple myeloma. Musto P; Fusilli S; Carotenuto M Leuk Lymphoma; 1994 Aug; 14(5-6):497-501. PubMed ID: 7812211 [TBL] [Abstract][Full Text] [Related]
30. Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significance. Millá F; Oriol A; Aguilar J; Aventín A; Ayats R; Alonso E; Domingo A; Feliu E; Florensa L; López A; Pérez-Vila E; Rozman M; Sánchez C; Vallespí T; Woessner S Am J Clin Pathol; 2001 Jan; 115(1):127-35. PubMed ID: 11190798 [TBL] [Abstract][Full Text] [Related]
31. [Clinical and electron microscopic studies in lymphoid plasmacellular reticulosis]. Pietschmann H; Stockinger L Blut; 1970 Feb; 20(2):76-85. PubMed ID: 4245216 [No Abstract] [Full Text] [Related]
32. Multiple myeloma presenting as massive ascites. Alacacioglu L; Turgut N; Piskin O; Ali Ozcan M; Hayri Ozsan G; Demirkan F; Undar B J BUON; 2009; 14(2):307-8. PubMed ID: 19650183 [TBL] [Abstract][Full Text] [Related]
33. The discriminating analysis in the differential diagnosis of monoclonal gammopathies. Büchi G; Veglio M; Reviglione G; Grosso E; Termine G; Girotto M; Autino R Pathologica; 1993; 85(1096):175-81. PubMed ID: 8361780 [TBL] [Abstract][Full Text] [Related]
34. Clinical diagnosis of the monoclonal gammopathies. Quittner H Ann Clin Lab Sci; 1974; 4(6):471-6. PubMed ID: 4215363 [No Abstract] [Full Text] [Related]
35. Telomerase activity in plasma cell dyscrasias. Xu D; Zheng C; Bergenbrant S; Holm G; Björkholm M; Yi Q; Gruber A Br J Cancer; 2001 Mar; 84(5):621-5. PubMed ID: 11237381 [TBL] [Abstract][Full Text] [Related]
36. [Interpretation of minimal medullary plasmacytoses in monoclonal dysglobulinemias. Importance of the study of osteomedullary biopsies of semi-thin sections and immunologic marking]. Canioni D; Kermarec J Ann Pathol; 1982; 2(4):279-92. PubMed ID: 6760876 [TBL] [Abstract][Full Text] [Related]
37. [Contemporaneous presentation of plasma cell leukemia and multiple myeloma. Description of a clinical case with a biclonal component]. Pasqualetti P; Casale R; Colantonio D; Natali G Minerva Med; 1987 Jul; 78(13):907-10. PubMed ID: 3601136 [TBL] [Abstract][Full Text] [Related]
38. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. International Myeloma Working Group Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789 [TBL] [Abstract][Full Text] [Related]
39. [Monoclonal myelomatous and non-myelomatous immunoglobulinemia: a contribution to differential diagnosis]. Romano L; Argenziano A; D'Agostino F; Cantatore D; Olivieri D Arch Monaldi; 1979; 34(3):132-7. PubMed ID: 555640 [No Abstract] [Full Text] [Related]